PMC:7172841 / 20626-20820
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T186 | 163-173 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T99 | 13-15 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T158 | 0-194 | Sentence | denotes | In contrast, IL-6 and CRP concentrations were significantly higher among patients with immune dysregulation than among patients at an intermediate state of immune activation (Figures 4K and 4L). |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T76 | 87-107 | Phenotype | denotes | immune dysregulation | http://purl.obolibrary.org/obo/HP_0002958 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T612 | 13-17 | PR:000001393 | denotes | IL-6 |
| T613 | 87-93 | UBERON:0002405 | denotes | immune |
| T614 | 94-107 | GO:0065007 | denotes | dysregulation |
| T615 | 156-162 | UBERON:0002405;GO:0006955 | denotes | immune |
| T616 | 163-173 | GO:0006955 | denotes | activation |
| T60768 | 2-12 | GO:0010467 | denotes | contrast, |
| T92597 | 16-19 | PR:000029150 | denotes | 6 a |
| T91530 | 26-35 | CL:0000576 | denotes | concentra |
| T73742 | 57-62 | UBERON:0002405 | denotes | ly hi |
| T87416 | 63-76 | GO:0065007 | denotes | her among pat |
| T12256 | 114-125 | DG_35 | denotes | mong patien |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 830 | 13-17 | Gene | denotes | IL-6 | Gene:3569 |
| 831 | 22-25 | Gene | denotes | CRP | Gene:1401 |
| 839 | 73-81 | Species | denotes | patients | Tax:9606 |
| 840 | 119-127 | Species | denotes | patients | Tax:9606 |